GlycoMimetics Inventory Turnover Ratio 2012-2019 | GLYC

GlycoMimetics inventory turnover ratio from 2012 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
GlycoMimetics Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.258B $0.000B
GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.060B 9.97
Zoetis (ZTS) United States $59.275B 35.46
Astellas Pharma (ALPMY) Japan $32.280B 16.12
Eisai (ESALY) Japan $21.727B 41.90
Grifols, S.A (GRFS) Spain $15.656B 20.51
UCB SA (UCBJF) Belgium $15.483B 0.00
Merck (MKGAF) Germany $14.519B 19.81
Neurocrine Biosciences (NBIX) United States $10.185B 480.83
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.869B 17.96
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.366B 10.69
Catalent (CTLT) United States $7.636B 31.07
IPSEN SA ADR (IPSEY) France $7.310B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.361B 96.32
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.058B 18.18
FibroGen (FGEN) United States $4.074B 119.72
United Therapeutics (UTHR) United States $3.933B 0.00
Sage Therapeutics (SAGE) United States $3.776B 0.00
Nektar Therapeutics (NKTR) United States $3.742B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.577B 13.07
Evotec AG (EVTCY) Germany $3.562B 58.28
PTC Therapeutics (PTCT) United States $2.974B 0.00
ArQule (ARQL) United States $2.423B 0.00
Heron Therapeutics (HRTX) United States $2.289B 0.00
Zogenix (ZGNX) United States $2.163B 0.00
Xencor (XNCR) United States $2.119B 64.41
Portola Pharmaceuticals (PTLA) United States $2.047B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.006B 63.95
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.979B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.906B 56.40
Tilray (TLRY) Canada $1.869B 0.00
ChemoCentryx (CCXI) United States $1.823B 0.00
USANA Health Sciences (USNA) United States $1.640B 17.50
Corcept Therapeutics (CORT) United States $1.472B 17.89
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.424B 9.71
Enanta Pharmaceuticals (ENTA) United States $1.314B 30.00
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.240B 0.00
Karyopharm Therapeutics (KPTI) United States $1.052B 0.00
Endo (ENDP) Ireland $1.050B 1.93
Aerie Pharmaceuticals (AERI) United States $1.042B 0.00
Radius Health (RDUS) United States $1.033B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.944B 0.00
Akebia Therapeutics (AKBA) United States $0.760B 0.00
Flexion Therapeutics (FLXN) United States $0.756B 0.00
Collegium Pharmaceutical (COLL) United States $0.702B 0.00
Dermira (DERM) United States $0.692B 0.00
TherapeuticsMD (TXMD) United States $0.624B 0.00
ImmunoGen (IMGN) United States $0.536B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.529B 0.00
Translate Bio (TBIO) United States $0.519B 0.00
Organogenesis Holdings (ORGO) United States $0.464B 0.00
Ardelyx (ARDX) United States $0.461B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.457B 55.38
Aptorum Group (APM) Hong Kong, SAR China $0.441B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.441B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.438B 18.88
Harpoon Therapeutics (HARP) United States $0.419B 0.00
Molecular Templates (MTEM) United States $0.395B 0.00
Indivior (INVVY) United States $0.392B 1.42
OptiNose (OPTN) United States $0.388B 0.00
Recro Pharma (REPH) United States $0.382B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.374B 0.00
DURECT (DRRX) United States $0.373B 0.00
Siga Technologies (SIGA) United States $0.364B 8.31
Lannett Co Inc (LCI) United States $0.363B 4.23
Innate Pharma SA (IPHYF) France $0.336B 0.00
Rafael Holdings (RFL) United States $0.327B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.326B 0.00
Jounce Therapeutics (JNCE) United States $0.306B 4.09
KalVista Pharmaceuticals (KALV) United States $0.302B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.270B 0.00
Calithera Biosciences (CALA) United States $0.244B 0.00
Concordia (CXRXF) Canada $0.230B 0.00
Xeris Pharmaceuticals (XERS) United States $0.224B 0.00
Concert Pharmaceuticals (CNCE) United States $0.215B 0.00
Ocular Therapeutix (OCUL) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 31.53
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.171B 0.00
IMV INC (IMV) Canada $0.149B 0.00
MEI Pharma (MEIP) United States $0.149B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.137B 0.00
Aquestive Therapeutics (AQST) United States $0.132B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.127B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
CV Sciences (CVSI) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.092B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.091B 0.00
CTI BioPharma (CTIC) United States $0.087B 0.00
MediWound (MDWD) Israel $0.084B 0.00
Capnia (SLNO) United States $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 24.09
Champions Oncology (CSBR) United States $0.079B 0.00
Aclaris Therapeutics (ACRS) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.070B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.070B 0.00
Nivalis Therapeutics (ALPN) United States $0.068B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
Natural Alternatives (NAII) United States $0.059B 14.73
Novan (NOVN) United States $0.059B 0.00
Genocea Biosciences (GNCA) United States $0.057B 0.00
Mast Therapeutics (SVRA) United States $0.056B 0.00
Forward Pharma (FWP) Denmark $0.054B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.045B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Opexa Therapeutics (ACER) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Shineco (TYHT) China $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
Melinta Therapeutics (MLNT) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Vical (BBI) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00